Albuminuria, but not metabolic syndrome, is a significant predictor of stroke recurrence in ischemic stroke

Journal of the Neurological Sciences

Volumn 277, Issue 1-2, 2009, Pages 50-53

  Yokota, Chiaki ^a   Minematsu, Kazuo ^a   Ito, Atsushi ^a   Toyoda, Kazunori ^a   Nagasawa, Hikaru ^a   Yamaguchi, Takenori ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Albuminuria; Japan; Metabolic syndrome; Predictor; Stroke recurrence

Indexed keywords

ADULT; AGED; ALBUMINURIA; ARTICLE; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; RECURRENT DISEASE; RISK FACTOR; SURVIVOR;

AGED; AGED, 80 AND OVER; ALBUMINURIA; BRAIN ISCHEMIA; DIABETES MELLITUS; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RECURRENCE; RISK FACTORS; STROKE;

EID: 58149280400     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2008.10.002     Document Type: Article

References (29)

1. Matsuzawa Y., Funahashi T., Kihara S., and Shimomura I. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 24 (2004) 29-33
2. Kurl S., Laukkanen J.A., Niskanen L., Laaksonen D., Sivenius J., Nyyssonen K., et al. Metabolic syndrome and the risk of stroke in middle-aged men. Stroke 37 (2006) 806-811
3. Chen H.J., Bai C.H., Yeh W.T., Chiu H.C., and Pan W.H. Influence of metabolic syndrome and general obesity on the risk of ischemic stroke. Stroke 37 (2006) 1060-1064
4. Iso H., Sato S., Kitamura A., Imano H., Kiyama M., Yamagishi K., et al. Metabolic syndrome and the risk of ischemic heart disease and stroke among Japanese men and women. Stroke 38 (2007) 1744-1751
5. Ninomiya T., Kubo M., Doi Y., Yonemoto K., Tanizaki Y., Rahman M., et al. Impact of metabolic syndrome on the development of cardiovascular disease in a general Japanese population: the Hisayama study. Stroke 38 (2007) 2063-2069
6. Marroquin O.C., Kip K.E., Kelley D.E., Johnson B.D., Shaw L.J., Bairey-Merz C.N., et al. Metabolic syndrome modifies the cardiovascular risk associated with angiographic coronary artery disease in women: a report from the Women's Ischemia Syndrome Evaluation. Circulation 109 (2004) 714-721
7. McNeill A.M., Rosamond W.D., Girman C.J., Heiss G., Golden S.H., Duncan B.B., et al. Prevalence of coronary heart disease and carotid arterial thickening in patients with the metabolic syndrome (the ARIC study). Am J Cardiol 94 (2004) 1249-1254
8. Ninomiya J.K., L'Italien G., Criqui M.H., Whyte J.L., Gamst A., and Chen R.S. Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey. Circulation (2004) 1094:42-46
9. Takeuchi H., Saitoh S., Takagi S., Ohnishi H., Ohhata J., Isobe T., et al. Metabolic syndrome and cardiac disease in Japanese men: applicability of the concept of metabolic syndrome defined by the National Cholesterol Education Program-Adult Treatment Panel III to Japanese men-the Tanno and Sobetsu study. Hypertens Res 28 (2005) 203-208
10. Wilson P.W., D'Agostino R.B., Parise H., Sullivan L., and Meigs J.B. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 112 (2005) 3066-3072
11. Ridker P.M., Buring J.E., Cook N.R., and Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation 107 (2003) 391-397
12. Sattar N., Gaw A., Scherbakova O., Ford I., O'Reilly D.S., Haffner S.M., et al. Metabolic syndrome with and without c-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 108 (2003) 414-419
13. Iglseder B., Cip P., Malaimare L., Ladurner G., and Paulweber B. The metabolic syndrome is a stronger risk factor for early carotid atherosclerosis in women than in men. Stroke 36 (2005) 1212-1217
14. Hassinen M., Komulainen P., Lakka T.A., Vaisanen S.B., Haapala I., Gylling H., et al. Metabolic syndrome and the progression of carotid intima-media thickness in elderly women. Arch Intern Med 166 (2006) 444-449
15. Empana J.P., Zureik M., Gariepy J., Courbon D., Dartigues J.F., Ritchie K., et al. The metabolic syndrome and the carotid artery structure in noninstitutionalized elderly subjects: the three-city study. Stroke 38 (2007) 893-899
16. Tzou W.S., Douglas P.S., Srinivasan S.R., Bond M., Tang R., Chen W., et al. Increased subclinical atherosclerosis in young adults with metabolic syndrome: the Bogalusa heart study. J Am Coll Cardiol 46 (2005) 457-463
17. Third report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Final report. Circulation 106 (2002) 3143-3421
18. World Health Organization. Definition, diagnosis and classification of diabetes mellitus: report of a WHO consultation. Part 1: diagnosis and classification of diabetes mellitus (1999), World Health Organization, Geneva. Switzerland WHO/NCD/NCS/99.2. 1999
19. Alberti K., Zimmet P., Shaw J., and IDF Epidemiology Task Force Consensus Group. The metabolic syndrome-a new worldwide definition. Lancet 366 (2005) 1059-1062
20. Matsuzawa Y. Metabolic syndrome-definition and diagnostic criteria in Japan. J Jpn Soc Int Med 94 (2005) 199-1003
21. Yokota C., Minematsu K., Hasegawa Y., and Yamaguchi T. Long-term prognosis, by stroke subtypes, after a first ever stroke: a hospital-based study over a 20-year period. Cerebrovasc Dis 18 (2004) 111-116
22. National Institute of Neurological Disorders and Stroke Ad Hoc Committee. Classification of cerebrovascular diseases III. Stroke 21 (1990) 637-676
23. Gerstein H.C., Mann J.F., Yi Q., Zinman B., Dinneen S.F., Hoogwerf B., et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 25 (2001) 421-426
24. Stehouwer C.D., Nauta J.J., Zeldenrust G.C., Hackeng W.H., Donker A.J., and den Ottolander G.J. Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus. Lancet 340 (1992) 319-323
25. Wada M., Nagasawa H., Kurita K., Koyama S., Arawaka S., Kawanami T., et al. Microalbuminuria is a risk factor for cerebral small vessel disease in community-based elderly subjects. J Neurol Sci 255 (2007) 27-34
26. Klausen K., Knut B.-J., Feldt-Rasmussen B., Jensen G., Clausen P., Scharling H., et al. Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation 110 (2004) 32-35
27. Ovbiagele B., Saver J.L., Lynn M.J., Chimowitz M., and WASID Study Group. Impact of metabolic syndrome on prognosis of symptomatic intracranial atherostenosis. Neurology 9 (2006) 1344-1349
28. Chapman N., Huxley R., Anderson C., Bousser M.G., Chalmers J., Colman S., et al. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Stroke 35 (2004) 116-121
29. Amarenco P., Bogousslavsky J., Callahan A., Goldstein L.B., Hennerici M., Rudolph A.E., et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 355 (2006) 549-559